Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,267 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection

NCT00183261

Conditions
Acute Retroviral Syndrome, Blood-Borne Infections, Communicable Diseases, +12 more
Locations
  • Ucsd Aiedrp San Diego, California, United States
  • Ucsf Aiedrp San Francisco, California, United States
  • LA Biomedical Research Institute at Harbor-UCLA AIEDRP Torrance, California, United States
  • Univ. of Colorado Health Sciences Ctr. AIEDRP Denver, Colorado, United States
View all 23 locations
View Trial Details
Completed

Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load

NCT01933594

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Massachusetts General Hospital CRS (MGH CRS) Boston, Massachusetts, United States
View Trial Details
Completed

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

NCT00125099

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Ucsd, Avrc Crs San Diego, California, United States
  • Massachusetts General Hospital ACTG CRS Boston, Massachusetts, United States
  • Brigham and Women's Hosp. ACTG CRS Boston, Massachusetts, United States
  • Aaron Diamond AIDS Research Ctr. AIEDRP New York, United States
View Trial Details
Completed

A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS

NCT00000992

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +18 more
Locations
  • USC CRS Los Angeles, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans, Louisiana, United States
View Trial Details
Completed

Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications

NCT01949116

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
View all 22 locations
View Trial Details
Completed

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children

NCT00006325

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Long Beach Memorial (Pediatric) Long Beach, California, United States
  • Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • UCSF / Moffitt Hosp - Pediatric San Francisco, California, United States
View all 15 locations
View Trial Details
Completed

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

NCT00028366

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • USC CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • The Ponce de Leon Ctr. CRS Atlanta, Georgia, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
View all 13 locations
View Trial Details
Completed

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

NCT00015652

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Univ. of Iowa Healthcare, Div. of Infectious Diseases Iowa City, Iowa, United States
View Trial Details
Completed

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

NCT00001067

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Howard University Hosp., Div. of Infectious Diseases, ACTU Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details

Related conditions